Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 103: 852-857, 2007. First published June 7, 2007; doi:10.1152/japplphysiol.00357.2007
8750-7587/07 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
103/3/852    most recent
00357.2007v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thijssen, D. H. J.
Right arrow Articles by Hopman, M. T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thijssen, D. H. J.
Right arrow Articles by Hopman, M. T. E.

Enhanced endothelin-1-mediated leg vascular tone in healthy older subjects

Dick H. J. Thijssen,1 Gerard A. Rongen,2,3 Arie van Dijk,3 Paul Smits,2,3 and Maria T. E. Hopman1

1Department of Physiology, Institute of Fundamental and Clinical Movement Sciences, Departments of 2Pharmacology and Toxicology, 3Internal Medicine, and 4Cardiology, Radboud University Nijmegen Medical Centre, The Netherlands

Submitted 2 April 2007 ; accepted in final form 5 June 2007


   ABSTRACT
TOP
 ABSTRACT
METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
Advanced age is associated with a decreased leg blood flow and reduced physical activity. Endothelin (ET-1), a powerful vasoconstrictor, may play a role in the increased leg vascular tone in older men. OBJECTIVES: to assess the ET-1-mediated vascular tone in the legs of healthy sedentary older men, both before and after 8 wk of exercise training. METHODS: in 8 younger subjects (19–50 yr) and 8 older men (67–76 yr), bilateral leg blood flow was measured using venous occlusion plethysmography before and after antagonizing ET-1 (using selective ETA/B-receptor antagonists). In older men, reversibility of the observations was assessed after 8 wk of cycling. RESULTS: ET-receptor inhibition increased leg blood flow significantly more in older men compared with younger individuals (29 ± 9% and 10 ± 4%, respectively, P < 0.05). Eight-week cycling training increased baseline blood flow in older men. The blood flow response to ET-receptor inhibition in older men was not affected by the training program (25 ± 8%, P > 0.05 for comparison with pretraining). The flow ratio (blood flows infused leg/noninfused leg) decreased significantly by training from 26 ± 8% to 7+3% (P < 0.05). CONCLUSION: the increased baseline vascular tone in aging is at least in part mediated by the endothelin. Eight-weeks cycling training in older sedentary men decreased leg vascular tone and seems to partly decrease the ET-1-mediated vascular tone.

endothelin; endothelium; exercise; cardiovascular disease

A COMMON FEATURE in older men is an increased baseline vascular tone (6, 7). Chronic increases in vascular tone have important implications for both vascular function and disease risk in humans (25). The age-related increase in vascular tone is in part mediated by a chronically elevated sympathetic {alpha}-adrenergic vasoconstriction (9). However, other factors may contribute. The endothelium plays an important role in the regulation of vascular tone via the release of dilator and constrictor substances. Endothelin-1 (ET-1; Ref. 44) is the most potent endothelium-derived constricting factor and contributes to the regulation of peripheral vascular tone (16, 18, 35, 43) by interacting with ETA (1)- and ETB-receptors (17) on smooth muscle and endothelial cells (5, 42).

Recently, animal studies demonstrated that aging leads to an augmented vasoconstrictor response to ET-1 in rat gastrocnemius (10) and coronary (24) vascular bed. Although some previous studies in humans reported increased ET-1 plasma levels in older humans (27, 28), this provides no information about the functional contribution of endogenous ET-1 to vascular tone. In the present study, we hypothesize that the age-related elevated vascular tone can be explained by an augmented contribution of an ET-1-mediated vasoconstriction. To address this hypothesis we examined the vasodilator response to combined ETA- and ETB-receptor antagonism in sedentary older men as well as in younger controls.

Aging is often associated with physical inactivity (40). Parallel to this, exercise training in older men improves vascular function (8), reduces plasma levels of ET-1 (27), and decreases vascular tone (6). To further explore the causal role of inactivity in age-related changes of the ET pathway, we repeated the experiments in the sedentary older men after 8 wk of cycling training. We hypothesize that cycling training in sedentary older men will increase leg baseline blood flow and partly decrease the ET-1-mediated vascular tone.


   METHODS
TOP
 ABSTRACT
 METHODS
RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
Subjects

Eight healthy sedentary older men (67–76 yr; Table 1), who were classified as sedentary (no regular exercise), and eight healthy control subjects (7 men and 1 woman, 19–50 yr; Table 1), participated in the study. The female subject was examined in the follicular phase. Sedentary older participants were included if they participated in <1 h exercise/wk for at least the past year or longer. Subjects never smoked or stopped smoking at least 15 yr ago. All subjects were screened prior to participation in the morning after an overnight fast. Subjects were included when they fulfilled the inclusion criteria: normotensive (blood pressure ≤140/90 mmHg, auscultatory measurement after at least 5 min seated rest), no hypercholesterolemia (total cholesterol <6.0 mM), and free of overt cardiovascular disease as assessed by medical history, physical examination, ankle-brachial pressure index, and ECG at rest. None of the subjects used medication known to interfere with the cardiovascular system (1 subject 400 mg beclometason daily, 1 subject 3,000 mg masalazine daily). The study was approved by the hospital ethics committee. All subjects gave their written informed consent before participation.


View this table:
[in this window]
[in a new window]

  		Table 1. Physical characteristics and the incremental maximal test of controls and older men before and after 8 wk of exercise training

 
Experimental Design

The study was designed in two separate parts. First, control subjects and older men were studied to quantify the vasodilator response to antagonizing ET receptors in the leg. Second, at least 2 wk thereafter, the older men started with an 8-wk cycling training program to examine whether the contribution of ET to leg vascular tone is reversible by training. For this purpose, exactly the same experimental protocol was repeated 4–5 days after the final training session.

Protocol

ET-receptor inhibition.   Experiments for both control subjects and the older men started at 8:30 AM after a 12-h overnight fast. All subjects refrained from caffeine-containing food and beverages, alcohol, and vitamin C for at least 18 h and did not perform any strenuous activities at least 48 h before testing. All tests were performed in a quiet, temperature-controlled room (23.5 ± 0.5°C) with the subjects in the supine position.

A modified Seldinger technique was used to introduce an intra-arterial cannula (Angiocath 16 gauge, Becton Dickinson, Sandy, UT) into the right femoral artery at the level of the inguinal ligament under local anesthesia (0.4 ml lidocaine 20 mg/ml). This cannula was used for the intra-arterial administration of ET-receptor antagonists by an automatic syringe infusion pump (Type P4000, Welmed, Hampshire, UK; Ref. 23) and for blood pressure measurement (monitor: Type 78353B, Hewlett-Packard, Houston, TX; transducer: Type PX600, Edwards Lifesciences Services, Unterschleissheim, Germany). Heart rate was recorded continuously with ECG (lead II). After complete instrumentation and at least 30 min after cannulation of the femoral artery, an arterial blood sample was collected in nonheparinized tubes and stored at –80°C for later analysis. Plasma ET-1 levels were determined using a chemoluminescent immunoassay with sensitivity for ET-1 of <0.16 pg/ml. The intra- and interassay variation coefficient is 2.5 and 10.2%, respectively (QuantiGlo, R&D Systems, Abingdon, UK). Subsequently, a 30-min measurement of baseline leg blood flow was performed, while saline was infused into the femoral artery. Bilateral leg blood flow was measured three to four times per minute, using ECG-triggered venous occlusion strain-gauge plethysmography as previously described (41). Briefly, an occlusion cuff (12-cm width) was placed proximally around the upper leg and was connected to a rapid cuff inflator (Hokanson, Bellevue, WA), which inflated the cuff (ECG triggered) to a pressure of 50 mmHg. This cuff pressure has been shown to be optimal to examine baseline blood flow using venous occlusion plethysmography (14). This pressure was sustained for nine heart beats, after which the cuff was instantaneously deflated (for 10 heart beats). A mercury-in-silastic strain gauge (Hokanson) was placed at midthigh, at least 10 cm above the patella and at least 4 cm below the cuff (41). The lower legs were supported 10 cm above heart level to facilitate venous outflow between the venous occlusion periods.

Pharmacological agents.   After the baseline measurements, the combined infusion of a selective ETA- and ETB-receptor antagonist (BQ-123 and BQ-788, respectively, Clinalfa, Calbiochem-Novabiochem, Läufelfingen, Switzerland) was started to inhibit the actions of the ET receptors of the right leg. BQ-123 has a high affinity for the ETA receptor (20) and is demonstrated to effectively counteract the vasoconstrictor effect of ET-1 infusion in the human forearm (18). BQ-788 is highly selective for the ETB receptor and antagonizes the vasoactive responses induced by an ETB-selective agonist (21). BQ-123 (10 nmol·min–1·liter leg volume–1) and BQ-788 (1 nmol·min–1·liter leg volume–1) were dissolved in saline, immediately prior to administration. During the whole protocol, infusion rate was kept constant at 0.1 ml·min–1·liter tissue–1. Infusion rate was adjusted to total leg volume, which was determined by anthropometry as described and validated by Jones and Pearson (22). The ET-receptor antagonists were infused for 75 min (13, 43). Previous studies showed that a 60-min coinfusion of BQ-123 and BQ-788 (at, respectively, 10 and 1 nmol·min–1·liter tissue–1 into the brachial artery) resulted in maximal vasodilation in the forearm of healthy subjects without triggering any systemic blood pressure effects (13, 19).

Physical training program.   The older men trained under supervision for 8 wk (3 sessions/wk) with at least 1 day between subsequent exercise bouts. A cycling ergometer (Lode, Angio300, Groningen, The Netherlands) was used for leg cycling exercise. Each session started with a 10-min warm-up at ~55% of the individual heart rate reserve (HRR), followed by 20-min cycling exercise at 65% HRR. Intensity of the exercise bouts was increased throughout the training period to a maximum of 85%HRR. In the first training session the average workload was 157 ± 48 kJ and in the 24th (i.e., last) training session, 234 ± 50 kJ.

Physical fitness.   In older men, physical fitness was assessed before and after the training by an incremental maximal exercise test on a cycling ergometer (Lode, Angio300) using a multistage protocol (workload increased by 10 W/min, starting at 10 W). Subjects were familiar with cycling exercise and were instructed to keep a constant pedaling rate of 60–80 revolutions/min (11). Oxygen consumption was measured continuously by a gas analyzer (Jaeger Benelux, Breda, The Netherlands) and averaged over 30-s intervals. Maximal oxygen consumption was determined as the mean of the last minute of the test. The criteria used to assess the quality of the maximal cycling test included 1) heart rate in excess of 90% of age predicted maximum (220–age); 2) respiratory exchange ratio ≥1.10, and 3) identification of a plateau (≤150 ml increase in 1 min) in oxygen consumption despite an additional increase in workload, which has been used previously (12). In all tests, at least two of the three criteria were met.

Data Analysis

Plethysmographic data of both legs were digitalized with a sample frequency of 100 Hz and analyzed offline by a customized computer program (Matlab, Mathworks). Leg blood flow (ml·min–1·dl leg tissue–1) was calculated as the slope of the volume change curve over a 4-s interval, starting directly after the inflation-induced cuff artifact (41). Leg vascular resistance was calculated as the mean arterial pressure {mmHg; calculated as diastolic pressure + [1/3·(systolic pressure – diastolic pressure)]} divided by leg blood flow (ml·min–1·dl–1) and expressed in arbitrary units (AU; mmHg·ml–1·min–1·dl–1). In addition, the ratio between the infused and control (contralateral) leg was calculated to correct for possible systemic changes (32).

Because of the anticipated differences in baseline leg blood flow and vascular resistance between controls and older men, the response to intra-arterial drug infusion was expressed as percentage changes from baseline. For this purpose, baseline blood flow, vascular resistance, and flow ratio were calculated by averaging registrations over a 10-min interval prior to the infusion of the ET-receptor antagonists. Likewise, blood flow, vascular resistance, and blood flow ratio were analyzed over the last 10 min of the intra-arterial drug infusion, where ET-receptor inhibition reached its maximal effect (36).

Statistics

The primary end point of this study is the vasodilator response to ET-receptor inhibition in the leg in controls vs. older men, as well as pre- vs. postcycling training in older men. In a pilot study (n = 8), we found a SD of 13% of the average vasodilator response (between groups) and 12% for within group comparison (before vs. after training). With a mean relevant effect of the ET inhibition of 20% (control vs. older men) or 15% (before vs. after training), we calculated that ({alpha} = 0.05), six to eight subjects would be needed to achieve a power of 80%. Kolmogorov-Smirnov tests indicated a normal distribution of data. Results are expressed as means ± SE, unless stated otherwise. To assess differences between controls and older men (unpaired) and between the pre- and posttraining measurement (paired), the effect of ET-receptor antagonism was compared using a t-test. To examine possible correlations between body mass index and the contribution of ET-1 to regulate vascular tone, Pearson correlation coefficient was used. Differences were considered to be statistically significant at a two-sided probability value of 0.05.


   RESULTS
TOP
 ABSTRACT
 METHODS
 RESULTS
DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
Baseline Characteristics

All older men successfully completed the training with a compliance with the training sessions of 100%. Leg volume, resting heart rate, and baseline leg blood flow and vascular resistance were not different between controls and healthy older men (Table 2). Diastolic and systolic blood pressure, ET-1 plasma levels, and cholesterol levels were not different between controls and healthy older men (Table 1). Body weight and body mass index were significantly larger in the older men compared with controls (Table 1).


View this table:
[in this window]
[in a new window]

  		Table 2. Vascular characteristics are presented for controls and older men before start of infusion (baseline) and at the end of the infusion of ET-receptor antagonists (last 10 min, end infusion)

 
ET-Receptor Inhibition in Controls and Older Men

Controls.   Inhibition of the ET receptors did not affect mean arterial pressure, heart rate, nor blood flow and vascular resistance in the noninfused leg in the control subjects (Table 2). The ET-receptor inhibition induced a small, but significant change in blood flow (10 ± 4%) and vascular resistance (–10 ± 4%) of the infused leg. As a consequence, the blood flow ratio between both legs increased significantly by 9 ± 4% (Figs. 1 and 2).


Figure 1
View larger version (10K):
[in this window]
[in a new window]

  		Fig. 1. Relative change in blood flow ratio in younger subjects (n = 8, 19–50 yr) and older men (n = 8, 67–76 yr), both before and after the training procedure during 75 min of endothelin (ET)-1 receptor inhibition.

 

Figure 2
View larger version (17K):
[in this window]
[in a new window]

  		Fig. 2. The mean (±SE) relative increase in blood flow ratio and vascular resistance (VR) during ET-receptor inhibition in younger subjects (n = 8, 19–50 yr) and older men (n = 8, 67–76 yr), both before and after the training procedure. *Significant relative increase from baseline. NS, not significant.

 
Older men.   During ET-receptor antagonism, heart rate and mean arterial pressure did not change significantly in older men (Table 2). However, blood flow increased (29 ± 9%) and vascular resistance decreased (–23 ± 7%) in the infused leg of the older men (Fig. 2). In the noninfused leg, no significant change in blood flow or vascular resistance was observed (Table 2). Inhibition of the ET receptors induced a significant increase in the blood flow ratio (26 ± 8%; Fig. 2).

Controls vs. older men.   In aged men, the increase in blood flow and in blood flow ratio in response to ET antagonism was more pronounced than in controls (Table 2, Fig. 2).

Effects of Cycling Training

In the group of sedentary older men, maximal workload during the cycling test was significantly increased after training (Table 1). Although not significant, maximal oxygen consumption tended to increase (P = 0.09). Submaximal oxygen consumption and power output at respiratory quotient 1.00 were significantly increased after training in older men. Heart rate was not changed at respiratory quotient 1.00 (Table 1). Systolic and diastolic blood pressure, leg volume, ET-1 plasma levels, and body mass did not change in the older men by training. Resting heart rate and baseline leg vascular resistance decreased significantly, while baseline leg blood flow increased by training (Tables 1 and 2).

After training, ET-receptor inhibition did not change mean arterial pressure, but was accompanied by a significant increase in heart rate (Table 2). Blood flow increased (25 ± 8%) and vascular resistance decreased (–16 ± 5%) in the infused leg during the ET-receptor inhibition (Table 2). Blood flow and vascular resistance of the noninfused leg did not significantly change during ET-receptor inhibition (Fig. 2). The blood flow ratio showed a small, but significant, increase after inhibition of the ET receptors (7 ± 3%, Table 2).

Pretraining vs. posttraining.   The response in heart rate and mean arterial pressure to ET antagonists did not differ between pre- and posttraining measurements. Also the changes in blood flow and vascular resistance in the infused and noninfused leg during ET-receptor inhibition did not change by training (Fig. 2). However, the increase in blood flow ratio during ET-receptor inhibition was significantly lower after training (Fig. 2).

Correlations

No correlation is present between the body mass index and the vasodilator response to ET-receptor antagonism in younger (r2 = 0.04, P = 0.66) or older subjects (r2 = 0.15, P = 0.39).


   DISCUSSION
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
ACKNOWLEDGMENTS
 REFERENCES
 
The present study demonstrates that 1) the relative contribution of ET-1 to vascular tone of the lower limbs is larger in older men compared with younger men, and 2) exercise training in sedentary older men increases basal leg blood flow, which may in part be mediated through the endothelin pathway. Thus the contribution of ET-1 to increased baseline leg vascular tone in older men may, at least in part, be reversible by endurance training.

Previous studies reported an age-related linear increase in leg vascular tone, resulting in a ~25% lower baseline leg blood flow in older compared with adolescent men (6, 7). Although not significant, the difference between controls and older men for blood flow (~15%) and vascular resistance (~30%) in the (non-)infused leg or pooled leg data are similar to previous studies (6, 7). Despite an age difference of 37 yr, the relatively large range in age in the younger group (19–50 yr) may contribute to the lack of difference in leg blood flow between both groups. Intensity of our exercise training is rather moderate compared with others (9, 38, 39), which may explain the nonsignificant change in maximal oxygen consumption. However, cycling training decreased leg baseline vascular tone, increased maximal oxygen consumption in 7 of 8 subjects, increased submaximal oxygen consumption and workload, and increased maximal workload during the cycling test. This indicates the effectiveness of our training program in the present study.

In previous studies, using the perfused forearm model, forearm blood flow increased by 35–60% during infusion of the ET-receptor antagonists BQ-123 and BQ-788 (18, 43). In contrast, we observed only a slight vasodilator effect of ET-1 inhibition (9% increase in blood flow) in the leg of healthy subjects. The difference in response to ET-receptor inhibition between forearm and leg vascular bed suggests that ET-1 has a different physiological effect on the lower limbs than on the upper limbs in healthy subjects. Recently, significantly different responses are reported for human forearm and leg vascular beds to endothelium-dependent (acetylcholine, substance P) and -independent (sodium nitroprusside) stimuli (29). Moreover, infusion of ET-1 in the rat hindquarters skeletal muscle bed results in a significantly lower vasoconstrictor response compared with the mesenteric bed (15). It may be hypothesized that the level of activity explains the differences in contribution of ET-1 to vascular tone between both limbs. The average level of skeletal muscle activity varies markedly between the upper and lower extremities. As bipeds, the legs are far more active during daily life (i.e., locomotion, standing) and during sports activities (i.e., running, cycling) than the human forearm.

We observed in the present study that healthy older men demonstrate a significantly larger vasodilator response to ET-receptor inhibition compared with younger subjects. This indicates that ET-1 may be a major contributor to the elevated baseline leg vascular tone in older men. This finding agrees with two recent studies in animals (2, 10) that reported an enhanced contribution of ET-1 to the increased baseline leg vascular tone with advanced age. However, the observation in the present study represents the first human study that demonstrates the role of ET-1 to leg vascular tone in older men.

Given the inclusion of healthy physically inactive older men, the larger vasoconstrictor response to ET-1 in older men can be explained by 1) a decreased level of physical fitness, and/or 2) the physiological aging process. To extend our knowledge about the age-related change in regulation of the ET pathway, older men performed an 8-wk aerobic cycling training. After training, the decrease in vascular resistance of the infused leg during ET-receptor inhibition in older men was lower than before training, but not significant. Expressing the effect of ET antagonists on vascular tone as flow ratio, to exclude small systemic effects (33), a significantly lower contribution of ET-1 to leg vascular tone is observed in older men after training. However, blood flow in the noninfused leg in the older men after training tended to increase during ET antagonism (Table 2). Although vascular resistance and flow ratio are well preferred over blood flow data (30, 31), this change in blood flow indicates that the response in flow ratio to ET-receptor inhibition after training should be interpreted with caution. Possibly, this has underestimated the vasodilator response in the infused leg after training when expressed as flow ratio. Nevertheless, our observations suggest that exercise training in older humans reduces the age-related increase in ET-1-mediated vascular tone, but does not normalize this response after 8 wk of cycling training.

Recently, the regulation of the ET pathway in sedentary and 12-wk trained older rats was examined (10) and demonstrated that advanced age enhances the ET-mediated vasoconstriction, whereas exercise training in older rats does not alter the ET-mediated vasoconstriction. The different finding regarding the effect of exercise training may be explained by the different species used (rats vs. humans). In addition, we examined older men before and after training (longitudinal), whereas Donato et al. (10) studied sedentary and trained older rats (cross-sectional). The latter design is less susceptible to detect small differences.

Our results lead to an interesting question regarding the mechanism behind the adaptations of the ET pathway in the older men. In the present study, ET-1 plasma levels were not different between controls and older men, but also no difference was found between pre- and posttraining. This suggests that plasma ET-1 levels unlikely explain the increased contribution of ET-1 to leg vascular tone with aging. In contrast, some studies demonstrated elevated ET-1 plasma levels with advanced age (3, 28), which decreased after endurance training (27). Because clearance of ET-1 and sensitivity of the receptors for ET-1 is lacking in all studies, the value of ET-1 plasma levels can be argued. In addition, a change in sensitivity (and/or density) of the ETA and/or ETB receptors or changes in ET-receptor signaling may explain the age-related upregulation of the ET pathway. Parallel to this, Donato et al. (10) recently reported that the augmented constrictor response to ET-1 in older rat skeletal muscle arterioles is mediated through an enhanced ETA-receptor signaling pathway. In contrast, Asai et al. (2) reported an impairment of the endothelial ETB receptors to cause the enhanced ET-1-mediated vasoconstriction in older monkeys. Future studies in humans should further elucidate the underlying mechanism of the age-related change in the ET pathway.

Apart from the contribution of ET-1 to the elevated vascular tone in older men, other factors are known to contribute as well. For example, a reduced nitric oxide-mediated vasodilation (37) and elevated sympathetic {alpha}-adrenergic vasoconstriction (9) partially contribute to the age-related increased vascular tone.

Although younger and older subjects differed regarding body mass index, this unlikely explains the increased vasodilator response to ET-receptor inhibition in the older men. A previous study demonstrated that lean, overweight, and obese subjects without hypertension demonstrate similar vasodilator responses to ET-receptor inhibition (4). Moreover, we found no correlation between body mass index and the vasodilator response to ET-receptor inhibition. In addition, the decrease in blood flow ratio after training in the older men was not accompanied by a decrease in BMI.

Limitations

In this study we used local infusions of drugs into the femoral artery. Since the leg represents an ~8-fold larger vascular bed compared with the forearm, higher dosages were necessary, and therefore systemic spillover effects may have occurred. However, we observed no change in mean arterial pressure or heart rate during ET-receptor inhibition, except for an increase in heart rate in the posttraining sessions of the older men. This latter change in heart rate may have been mediated by baroreceptor unloading due to a more generalized vasodilator response to ET-receptor inhibition. Accordingly, although not significant, blood flow in the noninfused leg tended to increase. To exclude the influence of systemic changes in blood pressure and heart rate on the ultimate results as much as possible (33), we expressed the effects of ET-1 on vascular tone as vascular resistance and blood flow ratio. Nevertheless, using the flow ratio only, one may underestimate the actual contribution of ET-1 to leg vascular tone after training in older men.

Increasing evidence supports a pathophysiological role for ET-1 in the modulation of vascular tone in cardiovascular disease (26, 34). Based on the constrictor action of ET-1 in older men, an enhanced ET-1 signal transduction mechanism may contribute to the elevations in skeletal muscle vascular resistance and, consequently, systemic vascular resistance. These changes in the ET pathway may partially explain the underlying mechanism for the predisposition of older men to cardiovascular pathology such as hypertension. Upregulation of the ET pathway in the older men may also result in media hypertrophy (34). This vascular remodeling process could further contribute to the development of hypertension. The physiological effect of exercise training in older men on the ET pathway potentially has beneficial consequences for vascular structure and function, but also for reducing the cardiovascular risk. However, future research is necessary to elucidate the clinical relevance of our observed physiological effect.

In conclusion, the enhanced activity of the endothelin pathway in older men compared with younger controls, suggests that ET-1 is a key mediator in the increased leg vascular tone with advancing age. These adaptations may be the result of a change in ET-receptor sensitivity or signaling, rather than changes in plasma levels of ET-1. In addition, 8 wk of exercise training decreases baseline leg vascular tone. Results of the present study suggest that this could in part be explained by a reduced contribution of the endothelin pathway in older men.


   ACKNOWLEDGMENTS
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
REFERENCES
 
We thank Rebecca Paulus and Jos Evers for their enthusiastic assistance during the training and Dr. Frans Boomsma (Erasmus MC, Rotterdam, The Netherlands) for the measurement of ET-1 plasma levels.


   FOOTNOTES
 

Address for reprint requests and other correspondence: M. T. E. Hopman, Dept. of Physiology, Radboud Univ. Nijmegen Medical Centre, Geert Grooteplein-Noord 21, 6525 EZ, Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands (e-mail: M.Hopman{at}fysiol.umcn.nl)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 

  1. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730–732, 1990.[CrossRef][Medline]
  2. Asai K, Kudej RK, Takagi G, Kudej AB, Natividad F, Shen YT, Vatner DE, Vatner SF. Paradoxically enhanced endothelin-B receptor-mediated vasoconstriction in conscious old monkeys. Circulation 103: 2382–2386, 2001.[Abstract/Free Full Text]
  3. Battistelli S, Gori S, Borgogni T, Manasse G. [Variation in the plasma endothelin levels in relation to age]. Minerva Cardioangiol 44: 111–114, 1996.[Medline]
  4. Cardillo C, Campia U, Iantorno M, Panza JA. Enhanced vascular activity of endogenous endothelin-1 in obese hypertensive patients. Hypertension 43: 36–40, 2004.[Abstract/Free Full Text]
  5. de Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 85: 9797–9800, 1988.[Abstract/Free Full Text]
  6. Dinenno FA, Jones PP, Seals DR, Tanaka H. Limb blood flow and vascular conductance are reduced with age in healthy humans: relation to elevations in sympathetic nerve activity and declines in oxygen demand. Circulation 100: 164–170, 1999.[Abstract/Free Full Text]
  7. Dinenno FA, Seals DR, DeSouza CA, Tanaka H. Age-related decreases in basal limb blood flow in humans: time course, determinants and habitual exercise effects. J Physiol 531: 573–579, 2001.[Abstract/Free Full Text]
  8. Dinenno FA, Tanaka H, Monahan KD, Clevenger CM, Eskurza I, DeSouza CA, Seals DR. Regular endurance exercise induces expansive arterial remodelling in the trained limbs of healthy men. J Physiol 534: 287–295, 2001.[Abstract/Free Full Text]
  9. Dinenno FA, Tanaka H, Stauffer BL, Seals DR. Reductions in basal limb blood flow and vascular conductance with human ageing: role for augmented alpha-adrenergic vasoconstriction. J Physiol 536: 977–983, 2001.[Abstract/Free Full Text]
  10. Donato AJ, Lesniewski LA, Delp MD. The effects of aging and exercise training on endothelin-1 vasoconstrictor responses in rat skeletal muscle arterioles. Cardiovasc Res 66: 393–401, 2005.[Abstract/Free Full Text]
  11. Fletcher GF, Balady GJ, Amsterdam EA, Chaitman B, Eckel R, Fleg J, Froelicher VF, Leon AS, Pina IL, Rodney R, Simons-Morton DA, Williams MA, Bazzarre T. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation 104: 1694–1740, 2001.[Free Full Text]
  12. Gavin TP, Robinson CB, Yeager RC, England JA, Nifong LW, Hickner RC. Angiogenic growth factor response to acute systemic exercise in human skeletal muscle. J Appl Physiol 96: 19–24, 2004.[Abstract/Free Full Text]
  13. Goddard J, Webb DJ. Endothelin antagonists and hypertension: a question of dose? Hypertension 40: e1–2, 2002.[Free Full Text]
  14. Groothuis JT, van Vliet L, Kooijman M, Hopman MT. Venous cuff pressures from 30 mmHg to diastolic pressure are recommended to measure arterial inflow by plethysmography. J Appl Physiol 95: 342–347, 2003.[Abstract/Free Full Text]
  15. Han SP, Trapani AJ, Fok KF, Westfall TC, Knuepfer MM. Effects of endothelin on regional hemodynamics in conscious rats. Eur J Pharmacol 159: 303–305, 1989.[CrossRef][ISI][Medline]
  16. Haynes WG, Ferro CJ, O'Kane KP, Somerville D, Lomax CC, Webb DJ. Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans. Circulation 93: 1860–1870, 1996.[Abstract/Free Full Text]
  17. Haynes WG, Strachan FE, Webb DJ. Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation 92: 357–363, 1995.[Abstract/Free Full Text]
  18. Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 344: 852–854, 1994.[CrossRef][ISI][Medline]
  19. Helmy A, Newby DE, Jalan R, Hayes PC, Webb DJ. Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide. Gut 52: 410–415, 2003.[Abstract/Free Full Text]
  20. Ihara M, Noguchi K, Saeki T, Fukuroda T, Tsuchida S, Kimura S, Fukami T, Ishikawa K, Nishikibe M, Yano M. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci 50: 247–255, 1992.[CrossRef][ISI][Medline]
  21. Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Fukuroda T, Fukami T, Ozaki S, Nagase T, Nishikibe M, Yano M. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci USA 91: 4892–4896, 1994.[Abstract/Free Full Text]
  22. Jones PR, Pearson J. Anthropometric determination of leg fat and muscle plus bone volumes in young male and female adults. J Physiol 204: 63P–66P, 1969.[Medline]
  23. Kooijman M, Rongen GA, Smits P, Hopman MT. Preserved alpha-adrenergic tone in the leg vascular bed of spinal cord-injured individuals. Circulation 108: 2361–2367, 2003.[Abstract/Free Full Text]
  24. Korzick DH, Muller-Delp JM, Dougherty P, Heaps CL, Bowles DK, Krick KK. Exaggerated coronary vasoreactivity to endothelin-1 in aged rats: role of protein kinase C. Cardiovasc Res 66: 384–392, 2005.[Abstract/Free Full Text]
  25. Lind L, Lithell H. Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia, and hyperinsulinemia. Am Heart J 125: 1494–1497, 1993.[CrossRef][ISI][Medline]
  26. Luscher TF. Endothelin: systemic arterial and pulmonary effects of a new peptide with potent biologic properties. Am Rev Respir Dis 146: S56–60, 1992.[ISI][Medline]
  27. Maeda S, Tanabe T, Miyauchi T, Otsuki T, Sugawara J, Iemitsu M, Kuno S, Ajisaka R, Yamaguchi I, Matsuda M. Aerobic exercise training reduces plasma endothelin-1 concentration in older women. J Appl Physiol 95: 336–341, 2003.[Abstract/Free Full Text]
  28. Miyauchi T, Yanagisawa M, Iida K, Ajisaka R, Suzuki N, Fujino M, Goto K, Masaki T, Sugishita Y. Age- and sex-related variation of plasma endothelin-1 concentration in normal and hypertensive subjects. Am Heart J 123: 1092–1093, 1992.[CrossRef][ISI][Medline]
  29. Newcomer SC, Leuenberger UA, Hogeman CS, Handly BD, Proctor DN. Different vasodilator responses of human arms and legs. J Physiol 556: 1001–1011, 2004.[Abstract/Free Full Text]
  30. O'Leary DS. Regional vascular resistance vs. conductance: which index for baroreflex responses? Am J Physiol Heart Circ Physiol 260: H632–H637, 1991.[Abstract/Free Full Text]
  31. Petrie JR, Perry C, Cleland SJ, Murray LS, Elliott HL, Connell JM. Forearm plethysmography: does the right arm know what the left is doing? Clin Sci (Lond) 98: 209–210, 2000.[Medline]
  32. Petrie JR, Ueda S, Morris AD, Murray LS, Elliott HL, Connell JM. How reproducible is bilateral forearm plethysmography? Br J Clin Pharmacol 45: 131–139, 1998.[CrossRef][ISI][Medline]
  33. Rongen GA, Lambrou G, Smits P. Flow ratios to express results obtained with the human in vivo ‘perfused forearm technique.’ Br J Clin Pharmacol 48: 258–261, 1999.[CrossRef][ISI][Medline]
  34. Schiffrin EL. Endothelin: potential role in hypertension and vascular hypertrophy. Hypertension 25: 1135–1143, 1995.[Abstract/Free Full Text]
  35. Spratt JC, Goddard J, Patel N, Strachan FE, Rankin AJ, Webb DJ. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men. Br J Pharmacol 134: 648–654, 2001.[CrossRef][ISI][Medline]
  36. Strachan FE, Spratt JC, Wilkinson IB, Johnston NR, Gray GA, Webb DJ. Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy men. Hypertension 33: 581–585, 1999.[Abstract/Free Full Text]
  37. Taddei S, Galetta F, Virdis A, Ghiadoni L, Salvetti G, Franzoni F, Giusti C, Salvetti A. Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes. Circulation 101: 2896–2901, 2000.[Abstract/Free Full Text]
  38. Tanaka H, Dinenno FA, Monahan KD, Clevenger CM, DeSouza CA, Seals DR. Aging, habitual exercise, and dynamic arterial compliance. Circulation 102: 1270–1275, 2000.[Abstract/Free Full Text]
  39. Tanaka H, Seals DR, Monahan KD, Clevenger CM, DeSouza CA, Dinenno FA. Regular aerobic exercise and the age-related increase in carotid artery intima-media thickness in healthy men. J Appl Physiol 92: 1458–1464, 2002.[Abstract/Free Full Text]
  40. Terjung RL, Zarzeczny R, Yang HT. Muscle blood flow and mitochondrial function: influence of aging. Int J Sport Nutr Exerc Metab 12: 368–378, 2002.[ISI][Medline]
  41. Thijssen DH, Bleeker MW, Smits P, Hopman MT. Reproducibility of blood flow and post-occlusive reactive hyperaemia as measured by venous occlusion plethysmography. Clin Sci (Lond) 108: 151–157, 2005.[Medline]
  42. Tsukahara H, Ende H, Magazine HI, Bahou WF, Goligorsky MS. Molecular and functional characterization of the non-isopeptide-selective ETB receptor in endothelial cells. Receptor coupling to nitric oxide synthase. J Biol Chem 269: 21778–21785, 1994.[Abstract/Free Full Text]
  43. Verhaar MC, Strachan FE, Newby DE, Cruden NL, Koomans HA, Rabelink TJ, Webb DJ. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation 97: 752–756, 1998.[Abstract/Free Full Text]
  44. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–415, 1988.[CrossRef][Medline]



This article has been cited by other articles:


Home page
 Age AgeingHome page
J. T. Groothuis, D. H. J. Thijssen, M. Kooijman, R. Paulus, and M. T. E. Hopman
Attenuated peripheral vasoconstriction during an orthostatic challenge in older men
Age Ageing, November 1, 2008; 37(6): 680 - 684.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. H. J. Thijssen, M. M. van Bemmel, L. M. Bullens, E. A. Dawson, N. D. Hopkins, T. M. Tinken, M. A. Black, M. T. E. Hopman, N. T. Cable, and D. J. Green
The impact of baseline diameter on flow-mediated dilation differs in young and older humans
Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1594 - H1598.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
D. H. J. Thijssen, G. A. Rongen, P. Smits, and M. T. E. Hopman
Physical (in)activity and endothelium-derived constricting factors: overlooked adaptations
J. Physiol., January 15, 2008; 586(2): 319 - 324.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
103/3/852    most recent
00357.2007v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thijssen, D. H. J.
Right arrow Articles by Hopman, M. T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thijssen, D. H. J.
Right arrow Articles by Hopman, M. T. E.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.